Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Detail)

v3.21.2
Accrued Expenses (Detail) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Accrued Liabilities Current [Abstract]    
External research and preclinical development $ 6,252 $ 4,702
Employee compensation and benefits 2,992 5,715
Professional fees 682 602
Facilities and other 37 65
Total accrued expenses $ 9,963 $ 11,084